Tenet Healthcare Surges to 235th in Trading Volume with $413 Million Day

On June 10, 2025, Tenet Healthcare (THC) saw a trading volume of $413 million, marking a 43.78% increase from the previous day. This surge placed THC at the 235th position in terms of trading volume for the day. However, the stock experienced a 5.79% decline, marking its third consecutive day of losses, with a total decrease of 8.89% over the past three days.

Tenet Healthcare has been identified as a strong momentum stock, with a Momentum Style Score of A. This score is part of the Zacks Style Scores system, which helps investors identify stocks with strong momentum. The score is influenced by factors such as price change and earnings estimate revisions. Tenet Healthcare currently has a Zacks Rank of #2 (Buy), indicating a positive outlook for the stock.

Analysts have set an average twelve-month price target of $182.24 for Tenet Healthcare, with the highest target being $230.00. This suggests a potential upside of 7.53% from the current price. The stock has shown strong performance over the past week, with a 1.59% increase, outperforming the Zacks Medical - Hospital industry, which saw a 0.71% gain. Over the past month, Tenet Healthcare's shares have risen by 15.2%, significantly outperforming the industry's 4.19% increase.

Looking at longer-term metrics, Tenet Healthcare's shares have risen by 39.77% over the past quarter and 28.21% over the past year, outperforming the S&P 500's 4.9% and 13.46% gains, respectively. This strong performance has been driven by positive earnings estimate revisions, with nine analysts revising their estimates upwards in the last 60 days, leading to an increase in the Zacks Consensus Estimate to $12.72 per share for fiscal 2025.

Recent analyst actions have also been positive for Tenet Healthcare. Morgan Stanley raised its price target to $210 from $175, while Royal Bank of Canada increased its target price to $189.00 from $183.00 and maintained an "outperform" rating. Additionally, Craig Hettenbach recommended buying Tenet Healthcare at $166.17, with a price target of $210, maintaining an "overweight" rating.